| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 10586676
[patent_doc_number] => 09308272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 14/323743
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12657
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323743 | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier | Jul 2, 2014 | Issued |
Array
(
[id] => 9857409
[patent_doc_number] => 20150037426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'MODIFIED STARCH MATERIAL OF BIOCOMPATIBLE HEMOSTASIS'
[patent_app_type] => utility
[patent_app_number] => 14/322861
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14796
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/322861 | Modified starch material of biocompatible hemostasis | Jul 1, 2014 | Issued |
Array
(
[id] => 10912826
[patent_doc_number] => 20140315839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/320808
[patent_app_country] => US
[patent_app_date] => 2014-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72659
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14320808
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/320808 | Pest control composition including novel iminopyridine derivative | Jun 30, 2014 | Issued |
Array
(
[id] => 10978478
[patent_doc_number] => 20160175421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'GLYCAN CONJUGATES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/392333
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 52258
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392333
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/392333 | Glycan conjugates and use thereof | Jun 26, 2014 | Issued |
Array
(
[id] => 11794166
[patent_doc_number] => 09403917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Preparation of poly alpha-1,3-glucan esters and films therefrom'
[patent_app_type] => utility
[patent_app_number] => 14/315387
[patent_app_country] => US
[patent_app_date] => 2014-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15062
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/315387 | Preparation of poly alpha-1,3-glucan esters and films therefrom | Jun 25, 2014 | Issued |
Array
(
[id] => 13137485
[patent_doc_number] => 10086054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => RM2 antigens and use thereof
[patent_app_type] => utility
[patent_app_number] => 14/392341
[patent_app_country] => US
[patent_app_date] => 2014-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 27
[patent_no_of_words] => 43305
[patent_no_of_claims] => 147
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 513
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392341
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/392341 | RM2 antigens and use thereof | Jun 25, 2014 | Issued |
Array
(
[id] => 12198545
[patent_doc_number] => 09901592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Methods for treating resistant diseases using triazole containing macrolides'
[patent_app_type] => utility
[patent_app_number] => 14/309202
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 32728
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309202
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/309202 | Methods for treating resistant diseases using triazole containing macrolides | Jun 18, 2014 | Issued |
Array
(
[id] => 10774831
[patent_doc_number] => 20160120987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/899041
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10176
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899041
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/899041 | Chemical structures for localized delivery of therapeutic agents | Jun 17, 2014 | Issued |
Array
(
[id] => 10945902
[patent_doc_number] => 20140348922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING AN HYDROUS CRYSTALLINE 2-O-ALPHA-D-GLUCOSYL-L-ASCORBIC ACID'
[patent_app_type] => utility
[patent_app_number] => 14/295546
[patent_app_country] => US
[patent_app_date] => 2014-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 36386
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/295546 | Process for producing a particulate composition comprising an hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid | Jun 3, 2014 | Issued |
Array
(
[id] => 11224471
[patent_doc_number] => 09452180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'NSAIDs-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof'
[patent_app_type] => utility
[patent_app_number] => 14/295154
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 10026
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/295154 | NSAIDs-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof | Jun 2, 2014 | Issued |
Array
(
[id] => 10782878
[patent_doc_number] => 20160129035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'COMBINED ANTI-ACID-FAST BACTERIAL AGENT, SCREENING METHOD FOR ANTI-ACID-FAST BACTERIAL AGENTS, AND ACTIVITY INHIBITOR OF WecA OR ORTHOLOG THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/895719
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10393
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14895719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/895719 | Combined anti-acid-fast bacterial agent, screening method for anti-acid-fast bacterial agents, and activity inhibitor of WecA or ortholog thereof | Jun 2, 2014 | Issued |
Array
(
[id] => 10939991
[patent_doc_number] => 20140343012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING JOINTS'
[patent_app_type] => utility
[patent_app_number] => 14/287809
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9923
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14287809
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/287809 | COMPOSITIONS AND METHODS FOR TREATING JOINTS | May 26, 2014 | Abandoned |
| 14/281036 | Antibacterial Therapy | May 18, 2014 | Abandoned |
Array
(
[id] => 10933123
[patent_doc_number] => 20140336144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'External Preparation Containing NSAIDS And Method For Producing The External Preparation'
[patent_app_type] => utility
[patent_app_number] => 14/281833
[patent_app_country] => US
[patent_app_date] => 2014-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13977
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281833
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/281833 | External Preparation Containing NSAIDS And Method For Producing The External Preparation | May 18, 2014 | Abandoned |
Array
(
[id] => 10968227
[patent_doc_number] => 20140371260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/280405
[patent_app_country] => US
[patent_app_date] => 2014-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33814
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14280405
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/280405 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | May 15, 2014 | Abandoned |
Array
(
[id] => 11449202
[patent_doc_number] => 09572828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-21
[patent_title] => 'Treatment for melanoma'
[patent_app_type] => utility
[patent_app_number] => 14/280376
[patent_app_country] => US
[patent_app_date] => 2014-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12606
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14280376
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/280376 | Treatment for melanoma | May 15, 2014 | Issued |
Array
(
[id] => 10799129
[patent_doc_number] => 20160145286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'Novel Crystalline Hydrates of 1-(Beta-D-Glucopyranosyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2-Thienylmethyl]Benzene'
[patent_app_type] => utility
[patent_app_number] => 14/888961
[patent_app_country] => US
[patent_app_date] => 2014-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12359
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888961
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/888961 | Crystalline hydrates of 1-(b-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene | May 6, 2014 | Issued |
Array
(
[id] => 10742713
[patent_doc_number] => 20160088864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'LIQUID OR SEMI-LIQUID PHARMACEUTICAL, DIETARY OR FOOD COMPOSITION FREE OF BITTERNESS CONTAINING AN ARGININE SALT'
[patent_app_type] => utility
[patent_app_number] => 14/787924
[patent_app_country] => US
[patent_app_date] => 2014-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6113
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/787924 | Liquid or semi-liquid pharmaceutical, dietary or food composition free of bitterness containing an arginine salt | Apr 29, 2014 | Issued |
Array
(
[id] => 10542098
[patent_doc_number] => 09267213
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-02-23
[patent_title] => 'Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array'
[patent_app_type] => utility
[patent_app_number] => 14/266595
[patent_app_country] => US
[patent_app_date] => 2014-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15404
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14266595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/266595 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | Apr 29, 2014 | Issued |
Array
(
[id] => 10729650
[patent_doc_number] => 20160075799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'A METHOD FOR PRODUCING ACTIVATED SUGAR CHAIN DERIVATIVE AND ACTIVATED SUGAR CHAIN DERIVATIVE PRODUCED THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 14/784923
[patent_app_country] => US
[patent_app_date] => 2014-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23007
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14784923
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/784923 | Method for producing activated sugar chain derivative and activated sugar chain derivative produced therefrom | Apr 16, 2014 | Issued |